Molecular hyperselection for optimal choice of first-line targeted therapy independent of primary tumor sidedness: An exploratory analysis of the randomized FIRE-3 study performed in RAS wild-type metastatic colorectal cancer

Molecular hyperselection facilitated by next generation sequencing could replace primary tumor sidedness as a tool of decision making for optimal choice of targeted therapy in first-line treatment of RAS wild-type mCRC.

Authors

Institutions

Publication Details

Journal
European Journal of Cancer
Published
2025-04-06
DOI
https://doi.org/10.1016/j.ejca.2025.115399
Citations
5
Primary Topic
Colorectal Cancer Treatments and Studies
Type
article
Field-Weighted Citation Impact
5.23
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Molecular hyperselection for optimal choice of first-line targeted therapy independent of primary tumor sidedness: An exploratory analysis of the randomized FIRE-3 study performed in RAS wild-type metastatic colorectal cancer

Lena Weiss, Arndt Stahler, Alexander Kiani, Sebastian Stintzing et al.
5 citations
European Journal of Cancer
Colorectal Cancer Treatments and Studies
5.23
article

Molecular hyperselection for optimal choice of first-line targeted therapy independent of primary tumor sidedness: An exploratory analysis of the randomized FIRE-3 study performed in RAS wild-type metastatic colorectal cancer

Lena Weiss, Arndt Stahler, Alexander Kiani, Sebastian Stintzing, Thomas Decker, Julian Walter Holch, Andreas Werner Jung, Ursula Vehling‐Kaiser, Dominik Paul Modest, Annabel Helga Sophie Alig, Kathrin Heinrich, Christoph Kahl, Tobias Heintges, Ludwig Fischer von Weikersthal, C. Benedikt Westphalen, G. Seipelt, Christian Lerchenmüller, Frank Kullmann, Salah-Edin Al-Batran, Volker Heinemann
article en
5 citations

Abstract

Molecular hyperselection facilitated by next generation sequencing could replace primary tumor sidedness as a tool of decision making for optimal choice of targeted therapy in first-line treatment of RAS wild-type mCRC.

European Journal of CancerVol. 221
Goethe University Frankfurt (DE), University of Applied Sciences Landshut (DE), Bayreuth Medical Center (DE), LMU Klinikum (DE), Humboldt-Universität zu Berlin (DE), Klinikum Magdeburg (DE), Klinikum Weiden (DE), Institute of Clinical Cancer Research (DE), University Hospital Frankfurt (DE), Krankenhaus Nordwest (DE), University Hospital Magdeburg (DE), Praxis für Hämatologie und Onkologie (DE), Lukaskrankenhaus (DE), University of Rostock (DE), Freie Universität Berlin (DE), Charité - Universitätsmedizin Berlin (DE), Ludwig-Maximilians-Universität München (DE)
Good health and well-being
Openalex Percentile: Top 4%
Colorectal Cancer Treatments and Studies
5.23
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.